Literature DB >> 9489550

Production of endogenous interferon-alpha and beta in patients with multiple sclerosis.

K P Wandinger, P Reissland, H Kirchner, K Wessel, M Otto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9489550      PMCID： PMC2169956          DOI： 10.1136/jnnp.64.2.277a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis.

Authors:  Vinod S Ramgolam; Silva Markovic-Plese
Journal:  J Signal Transduct       Date:  2011-11-01

Review 2.  The molecular study of IFNβ pleiotropic roles in MS treatment.

Authors:  Maryam Kay; Zohreh Hojati; Fariba Dehghanian
Journal:  Iran J Neurol       Date:  2013

3.  TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.

Authors:  Carlos López-Gómez; Begoña Oliver-Martos; María-Jesús Pinto-Medel; Margarita Suardiaz; Virginia Reyes-Garrido; Patricia Urbaneja; Óscar Fernández; Laura Leyva
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-03-03       Impact factor: 10.154

Review 4.  Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.

Authors:  Giulio Podda; Mukanthu Nyirenda; James Crooks; Bruno Gran
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-28       Impact factor: 7.285
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.